Insider buying · SEC Form 4

Insider Buying — Nov 10, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

3insider buys
$12.4Mbought in total
3companies
0by CEOs, CFOs and other chiefs
LRNlargest: $8.10M

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
LRNStride, Inc.Dylan G. HaggartDirector$8.10M108,273$74.83AddedNov 9, 2026
Form 4 ↗
Purchased via Fivespan Partners LP in 3 tranches at $74.07–$74.88 on Nov 5; now $75.72 (+1.2%). High-conviction concentrated buy.
NATRNatures Sunshine Products, Inc.Phil Frohlich (Prescott Group Capital Management)10% Owner$2.85M291,666$9.77AddedNov 9, 2026
Form 4 ↗
Prescott Group bought 291,666 shares in 20 tranches at $9.50–$9.95 (avg $9.77); now $11.02 (+12.8%). Activist fund with 10%+ stake adding.
LBTYKLiberty Global Ltd.John C. Malone10% Owner$1.46M150,000$9.73AddedNov 10, 2026
Form 4 ↗
Class C shares; bought over Nov 6–9 at $9.68–$9.76 (avg ~$9.73); now $9.73 (flat). Malone holds 9.2M+ direct Class C shares.

AIThe day in insider buying

SEC Form 4 Insider Scan — November 10, 2026

3 qualifying open-market purchases found in the last 24 hours totaling $12,411,028 combined.


Headline Filings

LRN — Stride, Inc. | Director Dylan G. Haggart (via Fivespan Partners LP) purchased 108,273 shares across 3 tranches on November 5 at prices ranging $74.07–$74.88 (avg ~$74.84), totaling $8,102,301. Current price: $75.72 (+1.2% from buy avg). High-conviction concentrated buy from a director-linked fund.

NATR — Nature's Sunshine Products, Inc. | 10% owner Phil Frohlich (Prescott Group Capital Management) purchased 291,666 shares in 20 tranches at $9.50–$9.95 (avg ~$9.77), totaling $2,849,577. Current price: $11.02 (+12.8% from buy avg). Activist fund with 10%+ stake continuing to add aggressively.

LBTYK — Liberty Global Ltd. | 10% owner John C. Malone purchased 150,000 Class C shares over Nov 6–9 at $9.68–$9.76 (avg ~$9.73), totaling $1,460,150. Current price: $9.73 (flat from buy avg). Malone holds 9.2M+ direct Class C shares; continued accumulation at multi-year lows.


Themes

  • Small/mid-cap value: All three buys are in companies trading well below historical highs — NATR and LBTYK both under $12.
  • Activist & concentrated holders: Both NATR (Prescott Group) and LRN (Fivespan Partners) buys are from fund vehicles with concentrated positions.
  • Malone at Liberty Global: A recurring insider buyer in Liberty assets; this continues a pattern of accumulation in LBTYK Class C.

Most-bought stocks, last 30 days

  • CRBG $115M · 12 buys, 2 insidersCorebridge Financial, Inc.
  • LRN $57.1M · 5 buys, 3 insidersStride, Inc.
  • LYCA $37.7M · 1 buyLycia Therapeutics, Inc.
  • BORR $33.3M · 5 buysBorr Drilling Ltd
  • COUR $31.4M · 1 buyCoursera, Inc.
  • MSM $29.0M · 1 buyMSC Industrial Direct Co., Inc.
  • SIRI $26.9M · 1 buySirius XM Holdings Inc.
  • LYEL $25.0M · 1 buyLyell Immunopharma, Inc.
  • GPI $24.2M · 1 buyGroup 1 Automotive Inc.
  • GME $22.8M · 1 buyGameStop Corp.
  • DOLE $21.5M · 2 buys, 2 insidersDole plc
  • QVCG $16.7M · 1 buyQVC Group, Inc.
  • BPRE $13.1M · 3 buysBluerock Private Real Estate Fund
  • SRRK $12.0M · 1 buyScholar Rock Holding Corp
  • IAM $11.5M · 1 buyIambic Therapeutics, Inc.
  • GLXY $9.86M · 1 buyGalaxy Digital Inc.
  • INTC $9.71M · 1 buyIntel Corporation
  • GOLD $7.87M · 3 buys, 3 insidersGold.com, Inc.
  • APLD $6.66M · 2 buys, 2 insidersApplied Digital Corp.
  • ETRA $3.61M · 1 buyElectra Therapeutics, Inc.

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.